An integrated phenotyping and mouse model generation platform for mitochondrial disease and dysfunction. MitoCluster, a consortium led by Professor Robert Pitceathly, was awarded £2.93 million by the Medical Research Council (MRC) National Mouse Genetics Network. Research funded by the consortium commenced in April 2022, aiming to enhance the current understanding and treatment of primary mitochondrial diseases (PMDs), and other human conditions involving mitochondrial dysfunction, such as neurodegeneration, cancer, and aging.